Clostridium difficile-associated TMAO promotes PERK-dependent tumor cell pyroptosis in triple-negative breast cancer (TNBC), thereby increasing M1 macrophage and CD8+ T-cell infiltration to sensitize tumors to anti-PD-1 therapy [97] (Fig. 5). This evidence concerns the gene CD8A and neoplasm.